ACUTE HAEMORRHAGIC CONJUNCTIVITIS

ACUTE HAEMORRHAGIC CONJUNCTIVITIS was reported 30 times

These drug classes are most commonly taken by patients reporting ACUTE HAEMORRHAGIC CONJUNCTIVITIS:

# Drug Count
0 Nonsteroidal Anti-inflammatory Drug [EPC] 10
1 Corticosteroid [EPC] 4
2 Kinase Inhibitor [EPC] 4
3 Calcium Channel Blocker [EPC] 3
4 Cytochrome P450 3A Inhibitor [EPC] 3
5 Dihydropyridine Calcium Channel Blocker [EPC] 3
6 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3
7 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3
8 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3
9 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3
10 Protease Inhibitor [EPC] 3
11 Endothelin Receptor Antagonist [EPC] 2
12 Phosphodiesterase 5 Inhibitor [EPC] 2
13 Prostacyclin Receptor Agonist [EPC] 2
14 Proteasome Inhibitor [EPC] 2
15 Alkaloid [EPC] 1
16 Alkylating Drug [EPC] 1
17 Aminosalicylate [EPC] 1
18 Angiotensin 2 Receptor Blocker [EPC] 1
19 CD20-directed Cytolytic Antibody [EPC] 1
20 Catecholamine [EPC] 1
21 Epidermal Growth Factor Receptor Antagonist [EPC] 1
22 Factor Xa Inhibitor [EPC] 1
23 Interleukin-17A Antagonist [EPC] 1
24 Interleukin-4 Receptor alpha Antagonist [EPC] 1
25 Macrolide Antimicrobial [EPC] 1
26 Nucleoside Metabolic Inhibitor [EPC] 1
27 Platelet Aggregation Inhibitor [EPC] 1
28 Platinum-based Drug [EPC] 1
29 Purine Antimetabolite [EPC] 1
30 RANK Ligand Inhibitor [EPC] 1
31 Tetracycline-class Drug [EPC] 1
32 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
33 Vitamin B12 [EPC] 1
34 Vitamin C [EPC] 1
35 Vitamin D [EPC] 1
36 alpha-Adrenergic Agonist [EPC] 1
37 beta-Adrenergic Agonist [EPC] 1